Fluorescence Targeted Pelvic Lymph Node Mapping

• Status: Terminated
• Trial end date: 2018-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to assess the lymphatic drainage of rectal tumours by using ICG as a fluorescent non-specific marker. As a feasibility study, it will also assess its technique and timing along with its ability to assist in removing lymph nodes when it is clinically indicated.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Oxford University Hospitals NHS Trust

Criteria

Inclusion Criteria:

• Participant is willing and able to give informed consent for participation in the study.

• Male or Female, aged 18 years or above.

• Participant is undergoing elective curative surgery for rectal adenocarcinoma

• Participant is willing and able to comply with study requirements

Exclusion Criteria:

• Participant has history of or known allergy to indocyanine green

• Participant has history of or known allergy to iodides

• Participant suffers from hyperthyroidism or has a benign thyroid tumour

• Participant has renal failure

• Female participant currently pregnant, planning pregnancy or breast feeding